Identifying and Lowering Resident Fall Risk

Identifying and Lowering Resident Fall Risk

According to the CDC, more than one in four older adults fall annually. Injuries sustained from falls can have a significant impact on a senior’s health and independence. To combat this issue, the CDC’s STEADI-Rx program for fall prevention highlights nine specific drug classes that may inordinately contribute to resident fall risk.

PharMerica’s Falls Risk Report incorporates these CDC STEADI-Rx program medications and additionally accounts for medication anticholinergic burden – another parameter significantly tied to falls – to stratify residents by their relative risk for medication-induced falls.

The report is designed to aid a facility’s clinical care team in conducting comprehensive fall risk assessments for residents and to identify medications for further deprescribing evaluation.

Contact your consultant pharmacist to begin leveraging this tool in your community!